GENE - Genetic Technologies Limited Stock Price and Quote

GENE [NASD]

Healthcare | Diagnostics & Research | Australia

Index	-	P/E	-	EPS (ttm)	-0.38	Insider Own	-	Shs Outstand	15.39M	Perf Week	5.45%
Market Cap	24.36M	Forward P/E	-	EPS next Y	-	Insider Trans	-	Shs Float	13.92M	Perf Month	-6.45%
Income	-5.80M	PEG	-	EPS next Q	-	Inst Own	1.00%	Short Float / Ratio	1.88% / 0.11	Perf Quarter	20.83%
Sales	5.90M	P/S	4.13	EPS this Y	7.20%	Inst Trans	-22.79%	Short Interest	0.26M	Perf Half Y	-4.53%
Book/sh	0.48	P/B	2.42	EPS next Y	-	ROA	-42.50%	Target Price	-	Perf Year	-43.14%
Cash/sh	0.16	P/C	7.16	EPS next 5Y	-	ROE	-50.90%	52W Range	0.83 - 2.40	Perf YTD	24.73%
Dividend	-	P/FCF	-	EPS past 5Y	27.90%	ROI	-43.80%	52W High	-51.67%	Beta	1.62
Dividend %	-	Quick Ratio	2.00	Sales past 5Y	67.30%	Gross Margin	55.40%	52W Low	39.76%	ATR	0.07
Employees	52	Current Ratio	2.10	Sales Q/Q	443.70%	Oper. Margin	-	RSI (14)	48.75	Volatility	5.06% 5.43%
Optionable	Yes	Debt/Eq	0.05	EPS Q/Q	-40.50%	Profit Margin	-97.90%	Rel Volume	0.05	Prev Close	1.16
Shortable	Yes	LT Debt/Eq	0.03	Earnings	-	Payout	-	Avg Volume	2.29M	Price	1.16
Recom	-	SMA20	1.07%	SMA50	-4.48%	SMA200	-7.50%	Volume	109,844	Change	0.00%

Mar-27-23 08:00AM	GeneType Multi-Risk Test now includes Melanoma, Pancreatic Cancer & Atrial Fibrillation GlobeNewswire +6.36%
Mar-13-23 08:00AM	Back-to-back Studies Validate geneType Breast Cancer Risk Test GlobeNewswire
Feb-09-23 08:00AM	New Publication Highlights geneTypes Ability to Detect Breast Cancer Earlier and Provide Data for Risk Stratification GlobeNewswire +21.23%
Feb-07-23 10:00AM	Genetic Technologies Announces Closing of $5 Million Registered Direct Offering GlobeNewswire -7.91%
Feb-06-23 08:00AM	Genetic Technologies to Launch Ground-breaking Comprehensive Risk Test for Breast & Ovarian Cancer GlobeNewswire
08:35AM	Loading…
Feb-03-23 08:35AM	Genetic Technologies Announces $5 Million Registered Direct Offering GlobeNewswire +80.20%
08:00AM	GENE to Launch Worlds First Comprehensive Risk Test for Breast & Ovarian Cancer GlobeNewswire
07:52AM	Why Genetic Technologies Shares Are Skyrocketing During Premarket Session Benzinga
Feb-01-23 02:22PM	Genetic Technologies Shares Jump After Strategic Alliance With Qiagen Benzinga +13.19%
08:00AM	GTG to form Strategic Alliance with global testing leader QIAGEN GlobeNewswire
Jan-30-23 08:00AM	Quarterly Business Update December 2022; Sixth Consecutive Quarter of Growth GlobeNewswire -7.26%
Jan-24-23 08:00AM	Genetic Technologies Presented Improved Clinical Colorectal Cancer Risk Prediction Model Integrating Polygenic Risk at ASCOGI Cancer Symposium GlobeNewswire
Jan-11-23 08:00AM	Genetic Technologies Provides Business Update GlobeNewswire
Dec-06-22 08:00AM	GeneType published in PLOS ONE development of polygenic risk scores for cardiovascular diseases and type 2 diabetes GlobeNewswire
Nov-10-22 08:00AM	Webinar - Dr Erika Spaeth to interview A/Prof Charles Siles on risk assessment tests for serious disease GlobeNewswire
08:00AM	Loading…
Nov-09-22 08:00AM	Genetype for Ovarian Cancer Published in Prestigious European Journal of Cancer Prevention GlobeNewswire
Oct-25-22 09:14AM	Genetic Technologies Announces Q1 FY23 Quarterly Results and Investor Webinar Details GlobeNewswire
Oct-13-22 08:00AM	Genetic Technologies Limited Interview to Air on Bloomberg U.S. on the RedChip Money Report(R) ACCESSWIRE
Sep-29-22 08:00AM	Journal of Precision Medicine publication confirms GeneType Risk Test outperforms traditional risk assessments for breast cancer GlobeNewswire
Sep-02-22 08:00AM	Genetic Technologies Provides Update on US Operations and Payer Engagement GlobeNewswire
Aug-30-22 08:00AM	GENE Momentum building - a year in review GlobeNewswire
Jul-28-22 08:00AM	Gene achieves key milestones and growth GlobeNewswire
Jul-18-22 08:00AM	GeneType launches Multi-Test in Obstetrics clinics with more than 1,000 referring primary care physicians GlobeNewswire
Jul-14-22 08:00AM	Completion of AffinityDNA Acquisition expanding global direct-to-consumer business GlobeNewswire +7.58%
Jul-05-22 08:00AM	EasyDNA expands Indian and European markets; launching NIPT, Carrier testing and DNA storage GlobeNewswire +5.79%
Jul-01-22 08:00AM	GeneType Risk Assessment Test onboarding in 16 clinics GlobeNewswire
Jun-16-22 08:00AM	Transformational Pathway to US Payer System; Attributing US$1.4 Billion Health and Economic Benefit from geneType Breast Cancer Risk Assessment Test GlobeNewswire
May-16-22 09:00AM	Acquisition of global direct to consumer ecommerce business GlobeNewswire
Apr-08-22 08:00AM	Genetic Technologies drives leadership in precision medicine with Multi-Risk Test GlobeNewswire
Feb-23-22 08:00AM	US Patent Office Grants Patent for COVID-19 Risk Test GlobeNewswire
08:00AM	Loading…
Feb-22-22 08:00AM	GeneType Multi-Test Receives Regulatory Approval for Commercial Release in USA and Australia GlobeNewswire
Jan-19-22 09:00AM	Genetic Technologies Reports Q2 FY22 Cash Flow Results GlobeNewswire +5.64%
Dec-21-21 08:00AM	Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, Company, GENE, geneType), a global leader in genomics-based tests in health, wellness and serious disease provides the following business update: GlobeNewswire
Dec-10-21 07:30AM	GENE Presents Study Involving 200,000 Participants at 2021 San Antonio Breast Cancer Symposium GlobeNewswire
Dec-09-21 07:30AM	Genetic Technologies Announces New Partnership and geneType COVID-19 Risk Test Patent Allowance from the USPTO GlobeNewswire -5.79%
Oct-25-21 08:30AM	Genetic Technologies Reports Q1 FY22 Results GlobeNewswire
Oct-04-21 08:00AM	GENE Delivers Material 12-Fold Increase in Revenue in the Quarter Ended September 2021 GlobeNewswire
Sep-30-21 09:00AM	Genetic Technologies Limited Interview to Air on Bloomberg TV (U.S.) on the RedChip Money Report® GlobeNewswire
Sep-28-21 08:04AM	GENE Embarks on Breakthrough African American Collaboration for Breast Cancer as Part of Its Commitment to Ethnic Diversity GlobeNewswire
Sep-09-21 09:00AM	BelHealth Completes Asset Sale of General Genetics Corp. PR Newswire
Aug-31-21 09:00AM	Genetic Technologies Reports FY21 Results as it Turns the Corner on its Commercialization Strategy GlobeNewswire
Aug-16-21 08:00AM	Genetic Technologies Enters Multi-Billion-Dollar Consumer Genomics Market GlobeNewswire
Jul-26-21 08:25AM	Genetic Technologies Rapidly Accelerating Commercialization Plans GlobeNewswire
Jul-19-21 09:27AM	Genetic Technologies Acquires EasyDNA To Expand Into Wellness Testing Benzinga
08:00AM	Genetic Technologies Strengthens Global Leadership in Genomics with Acquisition of EasyDNA GlobeNewswire
Jul-09-21 08:00AM	Genetic Technologies Continues to Break New Ground as it Advances Development of its Predictive Risk Test for Multiple Cancers & Morbidities GlobeNewswire
Jun-11-21 08:00AM	US Patent Office Grants Foundational Pharmacogenomic Patent GlobeNewswire +9.13%
Jun-01-21 08:00AM	Genetic Technologies COVID-19 Risk Test Now Available in US through Partnership with Infinity BiologiX GlobeNewswire -6.57%
May-13-21 09:01AM	Genetic Technologies Interview to Air on Bloomberg Television U.S. on the RedChip Money Report® GlobeNewswire
Apr-26-21 08:00AM	Genetic Technologies COVID-19 Risk Test Approved for Commercial Release GlobeNewswire
Apr-12-21 09:37AM	Company News for Apr 12, 2021 Zacks -7.88%
08:15AM	Genetic Technologies appoints Mike Tonroe as CFO GlobeNewswire
Apr-09-21 11:15AM	Genetic Technologies Provides Update on COVID-19 Risk Test Launch GlobeNewswire +6.53%
Mar-04-21 07:00AM	Genetic Technologies Signs Multi-Year US Distribution Agreement for COVID Risk Test GlobeNewswire -8.17%
Feb-26-21 09:20AM	Genetic Technologies Limited Interview to Air on Bloomberg TV in the US on the RedChip Money Report® GlobeNewswire
Jan-25-21 04:00PM	Genetic Technologies Announces Closing of $6.56 Million Registered Direct Offering GlobeNewswire
Jan-21-21 11:30AM	Genetic Technologies Announces $6.56 Million Registered Direct Offering GlobeNewswire +27.44%
07:00AM	Genetic Technologies Provides Update on its COVID-19 Disease Severity Risk Test and Expansion into Germline Testing GlobeNewswire
Dec-02-20 09:00AM	Genetic Technologies Secures US and ANZ Distribution Rights for PREDICTIX GlobeNewswire
Dec-01-20 09:50AM	Have Insiders Been Buying Genetic Technologies Limited (ASX:GTG) Shares? Simply Wall St.
Nov-23-20 04:30PM	Genetic Technologies Interview Aired on Bloomberg International on the RedChip Money Report GlobeNewswire
Nov-17-20 08:30AM	Genetic Technologies to Hold Investor Webinar and Q&A Session on November 19 GlobeNewswire
Oct-01-20 08:00AM	Genetic Technologies Provides Update on COVID-19 Risk Test GlobeNewswire
Sep-15-20 08:00AM	Genetic Technologies Provides Update on COVID-19 Disease Severity Test Development GlobeNewswire
Sep-11-20 08:33AM	Genetic Technologies Announces US Sales Have Commenced via Online Health Platform GlobeNewswire +9.86%
Sep-01-20 04:45PM	Genetic Technologies Regains Compliance with Nasdaq Stockholders Equity Requirement GlobeNewswire
Jul-20-20 08:30PM	Genetic Technologies Announces Closing of $5.1 Million Registered Direct Offering GlobeNewswire -23.99%
Jul-16-20 08:02AM	Genetic Technologies Announces $5.1 Million Registered Direct Offering GlobeNewswire
Jul-15-20 08:00AM	Genetic Technologies Provides Update on COVID-19 Disease Severity Test GlobeNewswire +150.88%
Jun-23-20 08:00AM	Genetic Technologies CEO to Participate in Investor Webinar and Q&A Session on June 24, 2020 GlobeNewswire
Jun-18-20 08:00AM	US Patent Office Grants Key Risk Test Patent GlobeNewswire
Jun-04-20 04:49PM	Insider Buying: The Genetic Technologies Limited (ASX:GTG) Independent Non-Executive Chairman Just Bought 24% More Shares Simply Wall St.
May-28-20 09:00PM	Genetic Technologies Announces Closing of $8.0 Million Public Offering GlobeNewswire
May-26-20 09:22AM	Genetic Technologies Announces Pricing of $8.0 Million Public Offering GlobeNewswire -16.25%
May-22-20 04:05PM	Genetic Technologies Provides Operational Update - Successful Prototype Polygenic Risk Score for COVID-19 Created GlobeNewswire
May-20-20 09:15AM	Genetic Technologies - Accelerated development of new COVID-19 Polygenic Risk Test for Risk of Developing Life-Threatening Complications GlobeNewswire
Apr-23-20 08:00AM	Genetic Technologies Announces Closing of $1.44 Million Registered Direct Offering GlobeNewswire
Apr-20-20 08:00AM	Genetic Technologies Announces $1.44 Million Registered Direct Offering GlobeNewswire -17.39%
Apr-17-20 08:00AM	COVID-19 Testing Capacity at Genetic Technologies Accredited Laboratory GlobeNewswire +41.37%
Apr-06-20 06:00AM	Genetic Technologies Announces Closing of $1.8 Million Registered Direct Offering GlobeNewswire +5.52%
Apr-01-20 12:45PM	Genetic Technologies Announces $1.8 Million Registered Direct Offering GlobeNewswire -17.27%
09:00AM	Genetic Technologies Limited Announces Market Update on Sales, Early Test Results and Launch of Consumer Initiated Testing GlobeNewswire
Mar-13-20 08:15PM	Genetic Technologies Limited Announces Receipt of Delisting Notification Letter from Nasdaq GlobeNewswire -14.16%
Mar-12-20 07:35PM	Those Who Purchased Genetic Technologies (ASX:GTG) Shares Five Years Ago Have A 82% Loss To Show For It Simply Wall St.
Jan-13-20 09:00AM	Genetic Technologies to provide Corporate & Strategic Update at 2020 Biotech Showcase GlobeNewswire
Jan-07-20 11:45AM	20 Medical centers across 8 US states set to offer Breast Cancer Test GlobeNewswire +116.83%
Jan-06-20 11:24PM	Read This Before Selling Genetic Technologies Limited (ASX:GTG) Shares Simply Wall St. +6.65%
Dec-17-19 09:00AM	Genetic Technologies to Hold Investor Webinar and Q&A Session on December 18 GlobeNewswire -5.08%
Dec-10-19 07:00AM	Genetype for Breast Cancer commissioned with sales to commence First Quarter 2020 GlobeNewswire
Nov-15-19 08:30AM	Genetic Technologies Interview to Air on Bloomberg International on the RedChip Money Report GlobeNewswire
Nov-05-19 07:00AM	Genetic Technologies Provides Shareholder Update on Recent Achievements and Upcoming Milestones GlobeNewswire
May-22-19 03:11PM	Genetic Technologies Announces Offering of Approximately USD 1.2 Million of American Depository Shares GlobeNewswire -33.33%
May-17-19 01:30PM	Genetic Technologies Interview to Air on Bloomberg International on the RedChip Money Report GlobeNewswire
May-10-19 08:10AM	Genetic Technologies Limited (ASX Code: GTG; NASDAQ Ticker: GENE) announces successful completion of two new ground-breaking Genetic Risk Tests for Colorectal Cancer and for Breast Cancer GlobeNewswire +95.31%
May-03-19 08:45AM	Genetic Technologies Receives Nasdaq Notification Letter GlobeNewswire
Apr-15-19 09:00AM	Genetic Technologies and The Translational Genomics Research Institute of Phoenix, Arizona Sign Memorandum of Understanding GlobeNewswire
Apr-11-19 09:15AM	Genetic Technologies Asian Operations Established in Hainan, China GlobeNewswire
Feb-01-19 05:30AM	Genetic Technologies Limited Announces Research Collaboration with Two World-Renowned Medical Centres GlobeNewswire
Dec-21-18 05:30AM	Genetic Technologies Limited Provides End of Year Update on the Test Development Program GlobeNewswire +18.48%
Dec-20-18 06:04PM	Genetic Technologies Limited Announces New Biomedical Blockchain Joint Venture GlobeNewswire -13.22%

Genetic Technologies Limited, a molecular diagnostics company, provides predictive genetic testing and risk assessment tools to help physicians manage people's health in the United States, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. It operates in two segments, EasyDNA and GeneType/Corporate. The company offers BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons. In addition, the company offers various cancer risk assessment tests under the GeneType for Colorectal Cancer and GeneType for Breast Cancer brand names; and develops other risk assessment tests across a range of diseases, which include colorectal cancer, ovarian cancer, prostate cancer, coronary artery, and type 2 diabetes. Further, it offers genetic testing services, including medical, animal, forensic, and plant testing. The company has research and collaboration agreements with the University of Melbourne, Translational Genomics Research Institute, Memorial Sloan Kettering New York Cambridge University, the Ohio State University, and Shivom. Genetic Technologies Limited was incorporated in 1987 and is headquartered in Fitzroy, Australia.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Upgrade your FINVIZ experience